Regulatory CD4 CD8 Double Negative T Cells

  • Edward Y. Kim
  • Stephen C. Juvet
  • Li ZhangEmail author
Part of the Methods in Molecular Biology book series (MIMB, volume 677)


Peripheral αβTCR+CD3+CD4CD8 NK1.1/CD56 double-negative (DN) Treg cells are a relatively rare subset of regulatory cells found in both humans and mice, typically comprising less than 5% of the total peripheral T-cell pool. Numerous studies have shown that DN Tregs can inhibit CD4+ and CD8+ T-cell responses in vitro and in vivo using a variety of model systems [Zhang et al., Nature Medicine 6:782, 2000; Young et al., Blood 100:3408, 2002; Ford et al., Experimental Medicine 196:261, 2002; Young et al., Journal of Immunology 171:134, 2003; Ford et al., European Journal of Immunology 37:2234, 2007; Zhang et al., Blood 109:4071, 2007; Fischer et al., Blood 105:2828, 2005]. This chapter describes published methods for the phenotypic identification of DN Tregs, their isolation from secondary lymphoid organs of mice or human peripheral blood, activation and expansion, and assays for their ability to suppress T-cell proliferation, induce apoptosis, and promote tolerance to allografts in vivo.

Key words

Double-negative T cells Regulatory cells Transplant tolerance Autoimmunity Isolation Activation/expansion Suppression Apoptosis 



The authors would like to thank Ramesh Vanama and Betty Joe for technical assistance. E.Y.K and S.C.J. are recipients of Terry Fox Foundation Research Fellowships from the National Cancer Institute of Canada. S.C.J. was also supported by the Clinician-Scientist Training Program, Department of Medicine, University of Toronto. This work was supported by Canadian Institutes of Health Research grant # 14431 and CCS grant # 17157 to LZ.


  1. 1.
    Zhang ZX, Yang L, Young KJ, DuTemple B, Zhang L. (2000) Identification of a previously unknown antigen-specific regulatory T cell and its mechanism of suppression. Nature Medicine 6 :782.PubMedCrossRefGoogle Scholar
  2. 2.
    Ford MS, Young KJ, Zhang Z, Ohashi PS, Zhang L. (2002) The immune regulatory function of lymphoproliferative double negative T cells in vitro and in vivo. Journal of Experimental Medicine 196 :261.PubMedCrossRefGoogle Scholar
  3. 3.
    Fischer K, Voelkl S, Heymann J, Przybylski GK, Mondal K, Laumer M, Kunz-Schughart L, Schmidt CA, Andreesen R, Mackensen A. (2005) Isolation and characterization of human antigen-specific TCR alpha beta(+) CD4(–)CD8(–) double-negative regulatory T cells. Blood 105:2828.PubMedCrossRefGoogle Scholar
  4. 4.
    Ford McIntyre MS, Young KJ, Gao J, Joe B, Zhang L. (2008) Cutting edge: in vivo trogocytosis as a mechanism of double negative regulatory T cell-mediated antigen-specific suppression. Journal of Immunology 181:2271.Google Scholar
  5. 5.
    Ford MS, Zhang ZX, Chen W, Zhang L. (2006) Double-negative T regulatory cells can develop outside the thymus and do not mature from CD8+ T cell precursors. Journal of Immunology 177:2803.Google Scholar
  6. 6.
    Zhang D, Yang W, Degauque N, Tian Y, Mikita A, Zheng XX. (2007) New differentiation pathway for double-negative regulatory T cells that regulates the magnitude of immune responses. Blood 109 :4071.PubMedCrossRefGoogle Scholar
  7. 7.
    Lutz MB, Kukutsch N, Ogilvie AL, Rössner S, Koch F, Romani N, Schuler G. (1999) An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. Journal of Immunological Methods 223:77.PubMedCrossRefGoogle Scholar
  8. 8.
    Young KJ, Yang L, Phillips MJ, Zhang L. (2002) Donor-lymphocyte infusion induces transplantation tolerance by activating systemic and graft-infiltrating double-negative regulatory T cells. Blood 100 :3408.PubMedCrossRefGoogle Scholar
  9. 9.
    Meidenbauer N, Marienhagen J, Laumer M, Vogl S, Heymann J, Andreesen R, Mackensen A. (2003) Survival and tumor localization of adoptively transferred Melan-A-specific T cells in melanoma patients. Journal of Immunology 170 :2161.Google Scholar
  10. 10.
    Zhang ZX, Ma Y, Wang H, Arp J, Jiang J, Huang X, He KM, Garcia B, Madrenas J, Zhong R. (2006) Double-negative T cells, activated by xenoantigen, lyse autologous B and T cells using a perforin/granzyme-dependent, Fas-Fas ligand-independent pathway. Journal of Immunology 177:6920.Google Scholar
  11. 11.
    Zhang ZX, Stanford W, Zhang L. (2002) Ly-6A is critical for the function of double negative regulatory T cells. European Journal of Immunology 32:1584.PubMedCrossRefGoogle Scholar
  12. 12.
    Chen W, Ford M.S., Young K.J., Zhang L. (2003) Infusion of in vitro-generated DN T regulatory cells induces permanent cardiac allograft survival in mice. Transplantation Proceedings 35:2479.PubMedCrossRefGoogle Scholar
  13. 13.
    Young KJ, DuTemple B, Phillips MJ, Zhang L. (2003) Inhibition of graft-versus-host disease by double-negative regulatory T cells. Journal of Immunology 171:134. Google Scholar
  14. 14.
    Ford MS, Chen W, Wong S, Li C, Vanama R, Elford AR, Asa SL, Ohashi PS, Zhang L. (2007) Peptide-activated double-negative T cells can prevent autoimmune type-1 diabetes development. European Journal of Immunology 37:2234.PubMedCrossRefGoogle Scholar

Copyright information

© Humana Press 2010

Authors and Affiliations

  1. 1.Toronto General Hospital Research InstituteTorontoCanada

Personalised recommendations